The FDA-approved smoking cessation pill, varenicline, has emerged as a powerful ally in the battle against nicotine addiction, particularly for teens and young adults struggling with vaping.Recent clinical trials have shown staggering results: participants aged 16 to 25 who used this medication had over three times the success rate in quitting vaping compared to those receiving only behavioral counseling.